Contact Investor Relations

9595 Wilshire Boulevard, Ste. 900
Beverly Hills, CA 90212

Investor Relations and Corporate Communications

Request Investor Information

  • This field is for validation purposes and should be left unchanged.


December 5th, 2017

Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical Trials
View Release

July 18th, 2017

Rich Pharmaceuticals Announces Collaboration Agreement To Support The Development of Treatments For Parkinson’s Disease: Company Will Receive Cash and Stock and Plans to Pay One Third of the Shares Received in a Dividend to Shareholders
View Release

June 21st, 2017

Rich Pharmaceuticals Announces Principal Doctor for Clinical Trials
View Release

» View All News

Stock Price